Isoflavones, Equol and Cardiovascular Disease: Pharmacological and Therapeutic Insights
The DOI matches its Crossref record.
Abstract
Isoflavones are an important class of phytoestrogens that are found at extrememly high levels in soy. Up until recently, daidzein and genistein were considered to be the most important and hence most studied isoflavones, however more recently attention has shifted to isoflavone metabolies. Equol represents the main active product of daidzein metabolism, produced via specific microflora in the gut. It has a longer half life and greater biological activity, including superior antioxidant activity. Yet, whilst the majority of animals produce equol following soy consumption, as much as 30-50 % of the adult human population cannot. This inability to produce equol in as much as half the population is thought to provide some explanation for the failure of soy to reveal any substantial health benefits in clinical studies. This article will comprehensively review literature investigating the potential cardiovascular benefits of daidzein and its metabolites, paying particular attention to equol. It will focus on the relative vasorelaxant activity, effects on nitric oxide synthase (NOS), antioxidant activity and potential for the treatment and prevention of hypertension and stroke. Findings obtained in both animal and human studies will be reviewed with the hope of gaining an insight into the experimental and clinical importance of equol to the cardiovascular benefits of soy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Towards microbial fermentation metabolites as markers for health benefits of prebiotics
Verbeke, K. A., Boobis, A. R., Chiodini, A., Edwards, C. A., Franck, A., Kleerebezem, M., Nauta, A., Raes, J., van Tol, E. A. F., & Tuohy, K. M. (2015) · Nutrition Research Reviews · doi:10.1017/s0954422415000037 · Cited by 343
Up-regulating the Human Intestinal Microbiome Using Whole Plant Foods, Polyphenols, and/or Fiber
Tuohy, K. M., Conterno, L., Gasperotti, M., & Viola, R. (2012) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf2053959 · Cited by 271
Isolation of a human intestinal bacterium capable of daidzein and genistein conversion
Matthies, A., Blaut, M., & Braune, A. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01795-08 · Cited by 161
“The effects of isoflavones may be mediated by binding to the estrogen receptors, by inhibition of enzymes, or by their antioxidative properties (5, 10, 11, 29).”
BackgroundMatthies, A., Clavel, T., Gütschow, M., Engst, W., Haller, D., Blaut, M., & Braune, A. (2008) · Applied and Environmental Microbiology · doi:10.1128/aem.00555-08 · Cited by 141
“Besides hormone-dependent effects, isoflavones show hormone-independent activities, including antioxidative and antiproliferative properties and enzyme inhibition (18, 25, 41).”
BackgroundS-Equol, an Antioxidant Metabolite of Soy Daidzein, and Oxidative Stress in Aging
Jackson, R. L., Greiwe, J. S., & Schwen, R. J. (2014) · Aging · doi:10.1016/b978-0-12-405933-7.00015-9 · Cited by 4
Metadata
- Authors
- Jackman, K., Woodman, O., & Sobey, C.
- Venue
- Current Medicinal Chemistry
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2007-11-01
- Volume
- 14
- Issue
- 26
- Pages
- 2824-2830
- ISSN
- 0929-8673 (ISSN-L)
- OpenAlex
- W2139593007
- Cited by
- 84
- References
- 0
- FWCI
- 6.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Isoflavones, Equol and Cardiovascular Disease: Pharmacological and Therapeutic Insights. https://app.cochat.ai/papers/10.2174/092986707782360178
- The paper
- Jackman, K., Woodman, O., & Sobey, C. (2007). Isoflavones, Equol and Cardiovascular Disease: Pharmacological and Therapeutic Insights. Current Medicinal Chemistry. https://doi.org/10.2174/092986707782360178
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.